← Browse by Condition
Medical Condition

ulcerative colitis uc

Total Trials
3
Recruiting Now
3
Trial Phases
Phase 1

ClinicalMetric tracks all active clinical trials for ulcerative colitis uc sourced from ClinicalTrials.gov. Research in this area spans early-phase safety investigations through large Phase 3 confirmatory trials, conducted by NIH-funded academic centers, independent investigators, and pharmaceutical sponsors worldwide. Each listing is updated daily as new studies open enrollment and existing ones reach capacity or complete follow-up.

Trial listings include the NCT identifier, current recruitment status, phase classification, primary and secondary endpoints, estimated enrollment size, participating countries, and direct links to the full protocol on ClinicalTrials.gov. Eligibility criteria — including age range, disease stage, and prior treatment requirements — are documented for every study to help patients and clinicians assess suitability before contacting a trial site.

Frequently Asked Questions — ulcerative colitis uc Clinical Trials

How many clinical trials are currently recruiting for ulcerative colitis uc?
ClinicalMetric currently tracks 3 actively recruiting clinical trials for ulcerative colitis uc, sourced in real time from ClinicalTrials.gov. The total number of registered studies—including those not yet enrolling or in active follow-up—is 3. Trial availability changes daily as new studies open enrollment and existing ones reach capacity.
What trial phases are available for ulcerative colitis uc?
ulcerative colitis uc research spans Phase 1 (1 trial). Phase 1 studies evaluate safety and dosing in small groups, Phase 2 studies assess preliminary efficacy in 100–300 participants, and Phase 3 trials compare the new treatment against the standard of care in 300–3,000+ patients. Phase 4 post-approval studies monitor long-term outcomes in real-world populations.
How do I find out if I qualify for a ulcerative colitis uc clinical trial?
Eligibility criteria for ulcerative colitis uc trials vary by study and typically specify age range, disease stage or severity, prior treatment history, and specific diagnostic or laboratory parameters. Each listing on ClinicalMetric links to the full protocol on ClinicalTrials.gov, where inclusion and exclusion criteria are documented. Contact the sponsoring site's research coordinator directly to confirm your eligibility—your treating physician or specialist can also help identify the most appropriate trial based on your medical history and current treatment status.
Trial Phases
Phase 1
1
Top Sponsors
Tanta University 1 trial
Benethera (Shaoxing) Biotechnology Co., Ltd. 1 trial
Fuller Research Foundation 1 trial

Recruiting Clinical Trials

NCT06067698
Recruiting
Alpha Lipoic Acid in Ulcerative Colitis
Enrollment
60 pts
Location
Egypt
Sponsor
Tanta University
View Trial →
NCT07632573 Phase 1
Recruiting
A Phase I Study to Evaluate the Safety/Tolerability of BDHK-2009 Tablets in Healthy Adult
Enrollment
68 pts
Location
China
Sponsor
Benethera (Shaoxing) Biotechno...
View Trial →
NCT07524244
Recruiting
Ketogenic and Carnivore (Lion) Diets for Inflammatory Bowel Disease and Rheumatoid Arthritis
Enrollment
160 pts
Location
United States
Sponsor
Fuller Research Foundation
View Trial →

Related Conditions

ulcerative colitis (1) ulcerative colitis disorder (1) ulcerative colitis acute (1) ibd inflammatory bowel disease (1) cd crohn s disease (1) rheumatoid arthritis ra (1) crohn s disease cd (1)
ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer  ·  Last Reviewed: April 2026  ·  Data Methodology